Literature DB >> 33457430

Chemical profiling of selected Ayurveda formulations recommended for COVID-19.

Sulaiman C T1, Deepak M1, Ramesh P R2, Mahesh K2, Anandan E M3, Indira Balachandran1.   

Abstract

BACKGROUND: The novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is the global health concern since December 2019. It has become a big challenge for the researchers to find a solution for this newly evolved pandemic. In Ayurveda point of view, COVID-19 is a Janapadodhwamsa vikara (epidemic disease), a situation where the environment-air, water, land, and seasons-is vitiated, causing a simultaneous manifestation of a disease among large populations. The aim of this study is to identify the active compounds of selected Ayurveda medicines recommended for COVID-19.
RESULTS: The selected preparations are traditionally recommended for the management of various kinds of fever including the infectious ones and to enhance the immunity. HPTLC analysis of the same showed presence of many active molecules like umbelliferone, scopoletin, caffeic acid, ferulic acid, gallic acid, piperine, curcumin, berberine, and palmatine.
CONCLUSION: The study provided valuable scientific data regarding the active ingredients of the selected medicines with proven therapeutic potentials like anti-viral, immunomodulatory, and anti-inflammatory activities.
© The Author(s) 2020.

Entities:  

Keywords:  Ayurveda; COVID-19; HPTLC; Indukantham Kwatham; Mukkamukkatuvadi Gulika; Vilvadi Gulika

Year:  2021        PMID: 33457430      PMCID: PMC7799399          DOI: 10.1186/s43088-020-00089-1

Source DB:  PubMed          Journal:  Beni Suef Univ J Basic Appl Sci        ISSN: 2314-8535


  20 in total

1.  Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding.

Authors:  Bryan C Mounce; Teresa Cesaro; Lucia Carrau; Thomas Vallet; Marco Vignuzzi
Journal:  Antiviral Res       Date:  2017-03-24       Impact factor: 5.970

2.  Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway.

Authors:  Kyeongjin Kim; Kook Hwan Kim; Hye Young Kim; Hyun Kook Cho; Naoya Sakamoto; Jaehun Cheong
Journal:  FEBS Lett       Date:  2009-12-17       Impact factor: 4.124

3.  Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.

Authors:  Che C Colpitts; Luis M Schang; Heni Rachmawati; Anne Frentzen; Stephanie Pfaender; Patrick Behrendt; Richard J P Brown; Dorothea Bankwitz; Joerg Steinmann; Michael Ott; Philip Meuleman; Charles M Rice; Alexander Ploss; Thomas Pietschmann; Eike Steinmann
Journal:  Gut       Date:  2014-07       Impact factor: 23.059

4.  Antiviral activity of berberine and related compounds against human cytomegalovirus.

Authors:  Kyoko Hayashi; Kazuki Minoda; Yasuo Nagaoka; Toshimitsu Hayashi; Shinichi Uesato
Journal:  Bioorg Med Chem Lett       Date:  2007-01-04       Impact factor: 2.823

5.  Ayurvedic treatment of COVID-19: A case report.

Authors:  P L T Girija; Nithya Sivan
Journal:  J Ayurveda Integr Med       Date:  2020-06-19

6.  Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies.

Authors:  P S Venkateswaran; I Millman; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine.

Authors:  Daniel P Bezerra; Fernanda O de Castro; Ana Paula N N Alves; Cláudia Pessoa; Manoel Odorico de Moraes; Edilberto R Silveira; Mary Anne S Lima; Francisca Juliana M Elmiro; Nylane M N de Alencar; Rodney O Mesquita; Michael W Lima; Letícia V Costa-Lotufo
Journal:  J Appl Toxicol       Date:  2008-03       Impact factor: 3.446

Review 8.  COVID-19: A promising cure for the global panic.

Authors:  Balachandar Vellingiri; Kaavya Jayaramayya; Mahalaxmi Iyer; Arul Narayanasamy; Vivekanandhan Govindasamy; Bupesh Giridharan; Singaravelu Ganesan; Anila Venugopal; Dhivya Venkatesan; Harsha Ganesan; Kamarajan Rajagopalan; Pattanathu K S M Rahman; Ssang-Goo Cho; Nachimuthu Senthil Kumar; Mohana Devi Subramaniam
Journal:  Sci Total Environ       Date:  2020-04-04       Impact factor: 7.963

9.  COVID-19 pandemic: A pragmatic plan for ayurveda intervention.

Authors:  Sanjeev Rastogi; Deep Narayan Pandey; Ram Harsh Singh
Journal:  J Ayurveda Integr Med       Date:  2020-04-23

10.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.

Authors:  Huijun Chen; Juanjuan Guo; Chen Wang; Fan Luo; Xuechen Yu; Wei Zhang; Jiafu Li; Dongchi Zhao; Dan Xu; Qing Gong; Jing Liao; Huixia Yang; Wei Hou; Yuanzhen Zhang
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.